|
This is an index of adverse event reports related to Zenapax (Daclizumab). Click on the relevant link below to view a selection of reports according to the event's seriousness level and/or the nature of the adverse reaction. Or scroll down to view a sample of recent reports further on this page.
Our database includes reports from Jan 2007 to Dec 2007. The information is not vetted and should not be cosidered as verified clinical evidence.
All cases (63)
Cases resulting in a serious event (63)
Cases resulting in death (2)
Cases resulting in life threatening events (15)
Cases resulting in hospitalization (47)
Cases resulting in other serious reactions (18)
Below is a sample of adverse event reports reports related to Zenapax (Daclizumab). For a complete list and/or a specific selection of reports, please use the links in the index above.
Adverse event in 11 year old female receiving Zenapax (Daclizumab)
Reported by a consumer/non-health professional from India on 2007-10-26
Patient: 11 year old female, weighing 30.0 kg (66.0 pounds)
Adverse reactions / side effects: Anaemia, Renal Tubular Necrosis, Thrombocytopenia
Adverse event resulted in: hospitalization
Suspect drug(s):
Zenapax (Daclizumab)
Other drugs received by patient: Steroid NOS; Mycophenolate Mofetil
Adverse event in male receiving Zenapax (Daclizumab)
Reported by a physician from United States on 2007-10-24
Patient: male, weighing 106.3 kg (233.9 pounds)
Adverse reactions / side effects: Cellulitis, Ventricular Tachycardia
Adverse event resulted in: hospitalization
Suspect drug(s):
Prograf
Administration route: Oral
Indication: Prophylaxis Against Transplant Rejection
Start date: 2005-03-31
End date: 2007-03-01
Prograf
Administration route: Oral
Start date: 2007-03-01
Zenapax
Dosage: dose unknown
Administration route: Oral
Indication: Prophylaxis Against Transplant Rejection
Prednisone
Administration route: Oral
Indication: Prophylaxis Against Transplant Rejection
Cellcept
Administration route: Oral
Indication: Prophylaxis Against Transplant Rejection
Adverse event in male receiving Zenapax (Daclizumab)
Reported by a physician from Canada on 2007-10-23
Patient: male
Adverse reactions / side effects: Fluid Overload, Bladder Disorder, Cardiac Output Decreased
Adverse event resulted in: hospitalization
Suspect drug(s):
Rapamune
Administration route: Oral
Indication: Prophylaxis Against Transplant Rejection
Start date: 2005-01-17
End date: 2005-02-01
Rapamune
Dosage: unspecified
Administration route: Oral
Start date: 2005-02-01
Prednisone
Dosage: unspecified
Administration route: Oral
Indication: Prophylaxis Against Transplant Rejection
Zenapax
Dosage: unspecified
Indication: Prophylaxis Against Transplant Rejection
Mycophenolate Mofetil
Dosage: unspecified
Administration route: Oral
Indication: Prophylaxis Against Transplant Rejection
Adverse event in male receiving Zenapax (Daclizumab)
Reported by a physician from United States on 2007-10-22
Patient: male
Adverse reactions / side effects: Nephritis Interstitial, Renal Failure, Bronchitis, Hepatitis, Blood Glucose Increased
Adverse event resulted in: hospitalization
Suspect drug(s):
Rapamune
Administration route: Oral
Indication: Prophylaxis Against Transplant Rejection
Start date: 2005-01-06
End date: 2005-01-01
Rapamune
Administration route: Oral
Start date: 2005-01-01
Rapamune
Administration route: Oral
Cellcept
Dosage: unspecified
Administration route: Oral
Indication: Prophylaxis Against Transplant Rejection
End date: 2005-01-01
Prednisone
Administration route: Oral
Indication: Prophylaxis Against Transplant Rejection
Zenapax
Dosage: unspecified
Indication: Prophylaxis Against Transplant Rejection
Other drugs received by patient: Lopressor; Lasix; Lasix; Lasix; Clonidine; Clonidine; Clonidine; Norvasc; Flomax; Acyclovir; Lipitor; Dapsone; Dapsone; Macrodantin; Macrodantin; Lantus; Novolog; Procrit; Procrit; Procrit
Adverse event in 7 year old male receiving Zenapax (Daclizumab)
Reported by a physician from United States on 2007-10-16
Patient: 7 year old male
Adverse reactions / side effects: Diarrhoea, Blood Sodium Decreased, Pyelonephritis
Adverse event resulted in: hospitalization
Suspect drug(s):
Prograf
Indication: Renal Transplant
Start date: 2005-06-06
Zenapax
Dosage: 24 mg, total dose, iv nos; 24 mg, total dose, iv drip; every other week, iv nos
Indication: Renal Transplant
Start date: 2005-06-06
End date: 2005-06-06
Zenapax
Dosage: 24 mg, total dose, iv nos; 24 mg, total dose, iv drip; every other week, iv nos
Indication: Renal Transplant
Start date: 2005-06-21
End date: 2005-06-21
Zenapax
Dosage: 24 mg, total dose, iv nos; 24 mg, total dose, iv drip; every other week, iv nos
Indication: Renal Transplant
Start date: 2005-07-05
End date: 2005-07-05
Zenapax
Dosage: 24 mg, total dose, iv nos; 24 mg, total dose, iv drip; every other week, iv nos
Indication: Renal Transplant
Start date: 2005-07-19
End date: 2005-07-19
Zenapax
Dosage: 24 mg, total dose, iv nos; 24 mg, total dose, iv drip; every other week, iv nos
Indication: Renal Transplant
Start date: 2005-08-02
End date: 2005-08-02
Zenapax
Dosage: 24 mg, total dose, iv nos; 24 mg, total dose, iv drip; every other week, iv nos
Indication: Renal Transplant
Start date: 2005-08-23
End date: 2005-08-23
Zenapax
Dosage: 24 mg, total dose, iv nos; 24 mg, total dose, iv drip; every other week, iv nos
Indication: Renal Transplant
Start date: 2005-10-04
End date: 2005-10-04
Zenapax
Dosage: 24 mg, total dose, iv nos; 24 mg, total dose, iv drip; every other week, iv nos
Indication: Renal Transplant
Start date: 2005-12-06
End date: 2005-12-06
Zenapax
Dosage: 24 mg, total dose, iv nos; 24 mg, total dose, iv drip; every other week, iv nos
Indication: Renal Transplant
Start date: 2005-11-08
End date: 2006-11-08
Other drugs received by patient: Niferex (Folic Acid); Ciprodex (Dexamethasone, Ciprofloxacin)
Adverse event in male receiving Zenapax (Daclizumab)
Reported by a physician from United States on 2007-10-09
Patient: male, weighing 83.0 kg (182.6 pounds)
Adverse reactions / side effects: Photosensitivity Reaction, Dysphagia, Skin Exfoliation, Conjunctival Oedema, Perivascular Dermatitis, Condition Aggravated, Rash, Sunburn, Rash Macular, Conjunctival Hyperaemia, NO Therapeutic Response
Suspect drug(s):
Zenapax (Daclizumab)
Other drugs received by patient: Lortadine; Solu-Medrol; Benadryl; Pepcid; Medrol; Ketoconazole; Keri Lotion; Aveeno Oatmeal Bath; Triamicalone Cream
Adverse event in 16 year old female receiving Zenapax (Daclizumab)
Reported by a physician from United States on 2007-10-02
Patient: 16 year old female, weighing 64.0 kg (140.8 pounds)
Adverse reactions / side effects: Escherichia Urinary Tract Infection, Escherichia Bacteraemia
Adverse event resulted in: hospitalization
Suspect drug(s):
Prograf
Dosage: 2.5 mg, bid
Indication: Renal Transplant
Start date: 2005-09-21
Zenapax
Dosage: 60 mg, qow, iv nos: 60 mg, qow, iv nos : 65 mg, qow, iv nos : 65 mg, uid/qd, iv nos
Indication: Renal Transplant
Start date: 2005-09-22
End date: 2005-09-22
Zenapax
Dosage: 60 mg, qow, iv nos: 60 mg, qow, iv nos : 65 mg, qow, iv nos : 65 mg, uid/qd, iv nos
Indication: Renal Transplant
Start date: 2005-10-06
End date: 2005-10-06
Zenapax
Dosage: 60 mg, qow, iv nos: 60 mg, qow, iv nos : 65 mg, qow, iv nos : 65 mg, uid/qd, iv nos
Indication: Renal Transplant
Start date: 2005-10-20
End date: 2005-10-20
Zenapax
Dosage: 60 mg, qow, iv nos: 60 mg, qow, iv nos : 65 mg, qow, iv nos : 65 mg, uid/qd, iv nos
Indication: Renal Transplant
Start date: 2005-11-17
End date: 2005-11-17
Zenapax
Dosage: 60 mg, qow, iv nos: 60 mg, qow, iv nos : 65 mg, qow, iv nos : 65 mg, uid/qd, iv nos
Indication: Renal Transplant
Start date: 2005-11-18
End date: 2005-11-18
Other drugs received by patient: Zantac 150; Aranesp; Cleocin (Clindamycin Hydrochloride); Lisinopril; Zosyn; Levaquin
Adverse event in 19 year old male receiving Zenapax (Daclizumab)
Reported by a physician from United States on 2007-10-02
Patient: 19 year old male
Adverse reactions / side effects: Bacteria Urine Identified, Complications of Transplanted Kidney, Serratia Infection, Bacterial Pyelonephritis, Escherichia Infection
Adverse event resulted in: hospitalization
Suspect drug(s):
Prograf
Administration route: Oral
Indication: Prophylaxis Against Transplant Rejection
Zenapax
Dosage: 70 mg, total dose, iv nos
Indication: Renal Transplant
Start date: 2005-03-29
End date: 2005-03-29
Other drugs received by patient: NU-Iron (Polysaccharide-Iron Complex); Septra; Singulair; Norvasc; Prevacid; Aspirin
Adverse event in female receiving Zenapax (Daclizumab)
Reported by a physician from United States on 2007-07-25
Patient: female
Adverse reactions / side effects: Rash Erythematous, Alopecia, Lipodystrophy Acquired
Adverse event resulted in: hospitalization
Suspect drug(s):
Zenapax (Daclizumab)
Adverse event in female receiving Zenapax (Daclizumab)
Reported by a physician from Canada on 2007-07-03
Patient: female, weighing 58.3 kg (128.3 pounds)
Adverse reactions / side effects: Lymphoproliferative Disorder
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Tacrolimus
Administration route: Oral
Indication: Prophylaxis Against Transplant Rejection
Start date: 2005-03-08
End date: 2007-02-28
Zenapax
Dosage: unspecified dose and regimen
Indication: Prophylaxis Against Transplant Rejection
Prednisone TAB
Administration route: Oral
Indication: Prophylaxis Against Transplant Rejection
Mycophenolate Mofetil
Dosage: unspecified dose and regimen
Administration route: Oral
Indication: Prophylaxis Against Transplant Rejection
Adverse event in male receiving Zenapax (Daclizumab)
Reported by a physician from United States on 2007-07-02
Patient: male, weighing 101.0 kg (222.2 pounds)
Adverse reactions / side effects: Pulmonary Embolism
Adverse event resulted in: death, life threatening event
Suspect drug(s):
Rapamune
Administration route: Oral
Indication: Prophylaxis Against Transplant Rejection
Start date: 2005-04-20
Tacrolimus
Zenapax
Adverse event in male receiving Zenapax (Daclizumab)
Reported by a physician from United States on 2007-06-27
Patient: male, weighing 58.6 kg (128.9 pounds)
Adverse reactions / side effects: Kidney Transplant Rejection
Suspect drug(s):
Tacrolimus
Dosage: unknown
Administration route: Oral
Indication: Prophylaxis Against Transplant Rejection
Mycophenolate Mofetil
Dosage: unknown
Administration route: Oral
Indication: Prophylaxis Against Transplant Rejection
Prednisone TAB
Dosage: unknown
Administration route: Oral
Indication: Prophylaxis Against Transplant Rejection
Zenapax
Dosage: unknown
Indication: Prophylaxis Against Transplant Rejection
Adverse event in 5 year old female receiving Zenapax (Daclizumab)
Reported by a physician from United States on 2007-06-25
Patient: 5 year old female, weighing 24.5 kg (53.9 pounds)
Adverse reactions / side effects: Klebsiella Infection, Pathogen Resistance, Pyelonephritis
Adverse event resulted in: hospitalization
Suspect drug(s):
Prograf
Dosage: 4 mg, bid
Indication: Renal Transplant
Start date: 2007-04-06
Zenapax
Dosage: see image
Indication: Renal Transplant
Start date: 2006-05-26
End date: 2006-05-26
Zenapax
Dosage: see image
Indication: Renal Transplant
Start date: 2006-06-08
End date: 2006-06-08
Zenapax
Dosage: see image
Indication: Renal Transplant
Start date: 2006-07-06
End date: 2006-07-06
Zenapax
Dosage: see image
Indication: Renal Transplant
Start date: 2006-07-20
End date: 2006-07-20
Zenapax
Dosage: see image
Indication: Renal Transplant
Start date: 2006-08-10
End date: 2006-08-10
Zenapax
Dosage: see image
Indication: Renal Transplant
Start date: 2006-09-25
End date: 2006-09-25
Zenapax
Dosage: see image
Indication: Renal Transplant
Start date: 2006-10-26
End date: 2006-10-26
Zenapax
Dosage: see image
Indication: Renal Transplant
Start date: 2006-11-27
End date: 2006-11-27
Other drugs received by patient: Ranitidine HCL; Aranesp; Emla (Lidocaine, Prilocaine); Neutra-Phos (Sodium Phosphate Dibasic, Potassium Phosphate Dibasic, SO; Bicitra (Sodium Citrate, Citric Acid); Icar (Iron Pentacarbonyl); Furadantin
Adverse event in male receiving Zenapax (Daclizumab)
Reported by a physician from United States on 2007-05-21
Patient: male, weighing 106.3 kg (233.9 pounds)
Adverse reactions / side effects: Cellulitis, Ventricular Tachycardia
Adverse event resulted in: hospitalization
Suspect drug(s):
Prograf
Administration route: Oral
Indication: Prophylaxis Against Transplant Rejection
Start date: 2005-03-31
End date: 2007-03-01
Prograf
Administration route: Oral
Start date: 2007-03-01
Zenapax
Dosage: dose unknown
Administration route: Oral
Indication: Prophylaxis Against Transplant Rejection
Prednisone TAB
Administration route: Oral
Indication: Prophylaxis Against Transplant Rejection
Cellcept
Administration route: Oral
Indication: Prophylaxis Against Transplant Rejection
Adverse event in male receiving Zenapax (Daclizumab)
Reported by a physician from United States on 2007-05-16
Patient: male, weighing 106.3 kg (233.9 pounds)
Adverse reactions / side effects: Cellulitis, Intravascular Haemolysis, Ventricular Tachycardia, Mitral Valve Incompetence
Adverse event resulted in: hospitalization
Suspect drug(s):
Prograf
Administration route: Oral
Indication: Prophylaxis Against Transplant Rejection
Start date: 2005-03-31
End date: 2007-03-01
Prograf
Administration route: Oral
Start date: 2007-03-01
Zenapax
Dosage: dose unknown
Administration route: Oral
Indication: Prophylaxis Against Transplant Rejection
Prednisone TAB
Administration route: Oral
Indication: Prophylaxis Against Transplant Rejection
Mycophenolate Mofetil
Administration route: Oral
Indication: Prophylaxis Against Transplant Rejection
Adverse event in male receiving Zenapax (Daclizumab)
Reported by a physician from United States on 2007-04-23
Patient: male, weighing 93.0 kg (204.6 pounds)
Adverse reactions / side effects: Lung Neoplasm
Adverse event resulted in: hospitalization
Suspect drug(s):
Sirolimus
Administration route: Oral
Indication: Prophylaxis Against Transplant Rejection
Start date: 2005-03-06
Zenapax
Dosage: unknown
Indication: Prophylaxis Against Transplant Rejection
Tacrolimus
Dosage: unknown
Administration route: Oral
Indication: Prophylaxis Against Transplant Rejection
Adverse event in 50 year old male receiving Zenapax (Daclizumab)
Reported by a physician from India on 2007-04-20
Patient: 50 year old male
Adverse reactions / side effects: Anaphylactic Shock
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Zenapax (Daclizumab)
Other drugs received by patient: Rifampicin; Isoniazid; Ethambutol Hydrochloride; Prednisolone; Mycophenolate Mofetil; Cyclosporine
Adverse event in receiving Zenapax (Daclizumab)
Reported by a physician from Taiwan, Province of China on 2007-04-19
Patient:
Adverse reactions / side effects: Sepsis
Adverse event resulted in: death
Suspect drug(s):
Zenapax (Daclizumab)
Adverse event in 50 year old male receiving Zenapax (Daclizumab)
Reported by a physician from India on 2007-04-18
Patient: 50 year old male
Adverse reactions / side effects: Anaphylactic Shock
Suspect drug(s):
Zenapax (Daclizumab)
Other drugs received by patient: Rifampicin; Isoniazid; Ethambutol Hydrochloride
Adverse event in female receiving Zenapax (Daclizumab)
Reported by a physician from United States on 2007-04-18
Patient: female, weighing 55.4 kg (121.9 pounds)
Adverse reactions / side effects: Anaemia, Condition Aggravated, Hypertension
Adverse event resulted in: hospitalization
Suspect drug(s):
Rapamune
Administration route: Oral
Indication: Prophylaxis Against Transplant Rejection
Start date: 2004-08-12
Zenapax
Dosage: dose unknown
Administration route: Oral
Indication: Prophylaxis Against Transplant Rejection
Prednisone TAB
Administration route: Oral
Indication: Prophylaxis Against Transplant Rejection
Tacrolimus
Dosage: 4/4
Administration route: Oral
Indication: Prophylaxis Against Transplant Rejection
Other drugs received by patient: Ecotrin; Ganciclovir; Ferrous Sulfate; Bactrim; Pepcid; Synthroid; Toprol-XL; Adalat; Zestril; Zocor
Adverse event in female receiving Zenapax (Daclizumab)
Reported by a physician from Canada on 2007-04-09
Patient: female, weighing 58.3 kg (128.3 pounds)
Adverse reactions / side effects: Central Nervous System Lesion
Adverse event resulted in: hospitalization
Suspect drug(s):
Tacrolimus
Administration route: Oral
Indication: Prophylaxis Against Transplant Rejection
Start date: 2005-03-08
End date: 2007-02-28
Zenapax
Dosage: unspecified dose and regimen
Indication: Prophylaxis Against Transplant Rejection
Prednisone
Administration route: Oral
Indication: Prophylaxis Against Transplant Rejection
Mycophenolate Mofetil
Dosage: unspecified dose and regimen
Administration route: Oral
Indication: Prophylaxis Against Transplant Rejection
Adverse event in 53 year old male receiving Zenapax (Daclizumab)
Reported by a physician from Canada on 2007-04-05
Patient: 53 year old male, weighing 73.8 kg (162.4 pounds)
Adverse reactions / side effects: Anastomotic Complication, Urinary Tract Infection, Gastroenteritis Viral, Haematoma, Renal Failure Acute
Adverse event resulted in: hospitalization
Suspect drug(s):
Zenapax
Start date: 2004-10-05
End date: 2004-10-05
Zenapax
Dosage: a total of 4 doses.
Start date: 2004-10-06
End date: 2004-12-02
Mycophenolate Mofetil
Administration route: Oral
Start date: 2004-10-06
End date: 2004-11-14
Mycophenolate Mofetil
Administration route: Oral
Mycophenolate Mofetil
Administration route: Oral
Mycophenolate Mofetil
Administration route: Oral
Mycophenolate Mofetil
Administration route: Oral
Mycophenolate Mofetil
Administration route: Oral
Cyclosporine
Dosage: frequency reported as die.
Administration route: Oral
Start date: 2004-10-06
Cyclosporine
Administration route: Oral
End date: 2004-11-13
Cyclosporine
Administration route: Oral
Cyclosporine
Administration route: Oral
Cyclosporine
Administration route: Oral
Prednisone 50mg TAB
Administration route: Oral
Start date: 2004-10-12
End date: 2005-03-11
Prednisone 50mg TAB
Administration route: Oral
Prednisone 50mg TAB
Administration route: Oral
Other drugs received by patient: Pantoprazole Sodium; Lipitor; Valcyte; Aranesp; Norvasc; Thiazide; Septra; Actonel; Lopressor; Calcium; Lasix; Phosphate; Clavulin; Atacand; Catapres; Solu-Cortef; Heparin
Adverse event in 38 year old female receiving Zenapax (Daclizumab)
Reported by a consumer/non-health professional from United States on 2007-04-05
Patient: 38 year old female, weighing 63.0 kg (138.6 pounds)
Adverse reactions / side effects: Breast Cancer
Suspect drug(s):
Zenapax (Daclizumab)
Other drugs received by patient: Ambien; Ibuprofen; Rebif; Quinine; Gabapentin; Zanaflex; 1 Concomitant Drug; Interferon Beta-1A; 1 Concomitant Drug; 1 Concomitant Drug; Prednisone; Pregabalin; Lidocaine; Keflex; Emla; Albuterol; Flexeril; Acyclovir; Monistat; Nystatin; Fluconazole; Metronidazole; Clobetasol Propionate; Desonide; Benadryl; Nizoral; Metrogel; Hemorrhoidal Medication NOS; Tylenol W / Codeine; Gentamicin; 1 Concomitant Drug; Lidocaine; Septra DS; Rebif; Neurontin; Lyrica; Medrol; Famotidine
Adverse event in 59 year old male receiving Zenapax (Daclizumab)
Reported by a physician from Sweden on 2007-04-04
Patient: 59 year old male
Adverse reactions / side effects: Abdominal Pain, Atelectasis, Gastrointestinal Haemorrhage, Haemoglobin Decreased, Hepatic Haematoma, Hypopnoea, Pleural Effusion, Abdominal Distension, Platelet Count Decreased, Cardiovascular Disorder
Adverse event resulted in: life threatening event
Suspect drug(s):
Zenapax
Start date: 2004-06-22
Zenapax
Start date: 2004-06-29
Mycophenolate Mofetil
Start date: 2004-06-22
End date: 2004-06-22
Mycophenolate Mofetil
Start date: 2004-06-23
End date: 2004-06-27
Mycophenolate Mofetil
Administration route: Oral
Start date: 2004-06-28
Tacrolimus
Administration route: Oral
Start date: 2004-06-27
End date: 2004-06-28
Tacrolimus
Administration route: Oral
Start date: 2004-06-29
End date: 2004-06-29
Tacrolimus
Administration route: Oral
Start date: 2004-06-30
Methylprednisolone 16mg TAB
Start date: 2004-06-22
End date: 2004-06-22
Prednisolone
Start date: 2004-06-23
End date: 2004-06-23
Prednisolone
Start date: 2004-06-24
End date: 2004-06-24
Prednisolone
Start date: 2004-06-25
End date: 2004-06-25
Prednisolone
Start date: 2004-06-26
End date: 2004-06-26
Prednisolone
Start date: 2004-06-27
End date: 2004-06-27
Prednisolone
Start date: 2004-06-28
Dextran INJ
Indication: Thrombosis Prophylaxis
Start date: 2004-06-23
End date: 2004-06-24
Other drugs received by patient: Diprivan; Dopamin; Insulin; Morfin; Frusemide; Nystatin; Albumin (Human); Ampicillin; Cefotaxim; Omeprazole; Acetaminophen; Lidocain; Diazepam
Adverse event in 60 year old male receiving Zenapax (Daclizumab)
Reported by a physician from France on 2007-04-04
Patient: 60 year old male
Adverse reactions / side effects: Fatigue, Dyspnoea, Chest Pain, Cytomegalovirus Infection
Adverse event resulted in: hospitalization
Suspect drug(s):
Zenapax
Start date: 2005-11-09
End date: 2005-11-09
Zenapax
Start date: 2005-11-15
End date: 2005-11-15
Mycophenolate Mofetil
Start date: 2005-11-09
End date: 2005-11-12
Mycophenolate Mofetil
Start date: 2005-12-12
End date: 2005-12-12
Mycophenolate Mofetil
Administration route: Oral
Start date: 2005-11-13
End date: 2005-12-11
Mycophenolate Mofetil
Administration route: Oral
Start date: 2005-12-12
End date: 2005-12-12
Mycophenolate Mofetil
Administration route: Oral
Start date: 2005-12-13
End date: 2006-11-15
Methylprednisolone 16mg TAB
Start date: 2005-11-09
End date: 2005-11-16
Methylprednisolone 16mg TAB
Start date: 2006-07-21
End date: 2006-07-24
Prednisolone
Dosage: taper according to local protocol
Start date: 2005-11-16
Tacrolimus
Dosage: adjustment to reach pre-defined target levels
Administration route: Oral
Start date: 2005-11-12
End date: 2006-11-15
Other drugs received by patient: Piperacilline; Gentamicin; Ganciclovir; Valganciclovir HCL; Omeprazole; Esomeprazole Magnesium; Acide Ursodeoxycholique; Amphotericin B; Colistin; Atropine Sulfate; Aspegic 1000; Bactrim; Tazocilline
|
